Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Roche
Roche
Exelixis: First Partnered Program Enters Phase III
Seeking Alpha
Wed, 10/3/12 - 11:20 am
Exelixis
Roche
GSK
GDC-0973
MEK inhibitor
melanoma
Roche declines comment on report of Illumina bid, Bloomberg reports
Yahoo/Fly on the Wall
Tue, 10/2/12 - 11:57 am
Roche
Illumina
M&A
Assessing Peregrine And Seeking Upside In The Space
Seeking Alpha
Mon, 10/1/12 - 12:28 pm
Peregrine Pharmaceuticals
Galena Biopharma
Roche
Sunesis
Roche should pick up AbbVie or BMS, analyst thinks
Fierce Pharma
Fri, 09/28/12 - 10:49 am
AbbVie
Roche
Bristol-Myers Squibb
M&A
Illumina Aims at Roche for Tests Seen Worth $25 Billion
Bloomberg
Fri, 09/28/12 - 10:47 am
Roche
Illumina
DNA sequencing
How Many Pharmas Does It Take to Accelerate Drug Development?
Motley Fool
Tue, 09/25/12 - 10:04 am
drug development
Abbott Labs
AstraZeneca
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
GSK
JNJ
Pfizer
Roche
Sanofi
TransCelerate BioPharma
Roche $5.7 Billion Tumor Drug Sales Hinge on Rival Tests
Bloomberg
Mon, 09/24/12 - 11:04 am
Roche
cancer
Herceptin
Report: Roche's Zelboraf, BMS' Yervoy control their segment
Fierce Pharma
Fri, 09/21/12 - 01:13 pm
Roche
Zelboraf
Bristol-Myers Squibb
Yervoy
melanoma
The Top 5 Big Pharmaceuticals And Their Patent Cliffs
Seeking Alpha
Tue, 09/11/12 - 12:33 pm
patents
patent cliff
GSK
Novartis
Pfizer
Roche
Drugmakers 'could free $33 bln of working capital'-analysts
Reuters
Tue, 09/11/12 - 12:00 pm
Pfizer
Roche
Sanofi
Merck
AstraZeneca: Will New Drugs And CEO Reward Investors?
Seeking Alpha
Tue, 09/11/12 - 10:44 am
AstraZeneca
Roche
Pfizer
Forest Labs
Cubist Pharmaceuticals
Lung Cancer Genomic Mapping Yields New Targets, Researchers Say
Bloomberg
Mon, 09/10/12 - 10:43 am
genomic mapping
lung cancer
Pfizer
Iressa
Roche
Tarceva
Roche expects to keep Rituxan monopoly until 2015
Fierce Pharma
Fri, 09/7/12 - 12:22 pm
Roche
cancer
Rituxan
biosimilars
Roche ramps up Alzheimer's drug trial as rivals stumble
Yahoo/Reuters
Fri, 09/7/12 - 08:58 am
Roche
Alzheimer's disease
gantenerumab
Roche Hosts An Encouraging Investor Day
Seeking Alpha
Thu, 09/6/12 - 04:15 pm
Roche
JNJ
Immunogen
Abbott Labs
Illumina
Roche Vows To Keep Up R&D Spend, Go Beyond Cancer Therapies
NASDAQ.com
Wed, 09/5/12 - 10:58 am
Roche
R&D
This Drug Is Getting Some Negative ATTENTION: ArQule's Tivantinib
Motley Fool
Fri, 08/31/12 - 12:27 pm
tivantinib
Arqule
lung cancer
Tarceva
Roche
Astellas
Big Pharma betting billions in high-stakes hunt for the next Lipitor
Fierce Biotech
Wed, 08/29/12 - 12:21 pm
Big Pharma
Lipitor
Anacetrapib
Merck
Plavix
Pfizer
Bristol-Myers Squibb
PCSK9 inhibitor
Sanofi
Regeneron
darapladib
Roche
GSK
ImmunoGen Rises On Partner Roche’s Results
Bloomberg
Tue, 08/28/12 - 11:22 am
breast cancer
Roche
Immunogen
T-DM1
A New CEO for AstraZeneca
Motley Fool
Tue, 08/28/12 - 10:55 am
Pharma CEOs
AstraZeneca
Pascal Soriot
Roche
Pages
« first
‹ previous
…
80
81
82
83
84
85
86
87
88
…
next ›
last »